Resverlogix and China-based Shenzhen Hepalink Pharmaceutical Co., Ltd … – MarketWatch

Resverlogix and China-based Shenzhen Hepalink Pharmaceutical Co., Ltd
MarketWatch
Under the terms of the transaction, Hepalink will subscribe for 13,270,000 Resverlogix common shares and 1,000,000 common share purchase warrants, for aggregate proceeds of approximately CAD$35 million, or CAD$2.67 per unit. Each warrant is …

…read more

Scroll to Top